The Canadian College of Naturopathic Medicine   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Toronto Canada (1978)

Organization Overview

First Clinical Trial
2007
NCT00668707
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Canadian College of Naturopathic Medicine | Kieran Cooley | The Canadian College of Naturopathic Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Attention Deficit Disorder with Hyperactivity (Phase 3)

Colonic Diseases (Phase 2)

Colonic Diseases, Functional (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Digestive System Diseases (Phase 2)

Disease (Phase 3)

Epilepsy (Phase 3)

Gastrointestinal Diseases (Phase 2)

Hypercholesterolemia (Phase 2)

Hyperkinesis (Phase 3)

Irritable Bowel Syndrome (Phase 2)

Lung Neoplasms (Phase 3)

Recurrence (Phase 3)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 14
  • # of Trial APIs: 27